|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.504
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.495
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.487
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.445
|
|
|
|
regulation of histone h3 k4 methylation
|
GO:0051569 |
12 |
0.424
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.360
|
Mouse |
|
|
histone h4 k16 acetylation
|
GO:0043984 |
3 |
0.352
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.244
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.243
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.235
|
Mouse |
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.217
|
|
|
|
metanephric mesenchyme morphogenesis
|
GO:0072133 |
4 |
0.213
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.205
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.197
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.192
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.182
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.178
|
|
|
|
histone methylation
|
GO:0016571 |
71 |
0.175
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.174
|
Mouse |
|
|
neural tube closure
|
GO:0001843 |
90 |
0.165
|
|
|
|
histone h4 acetylation
|
GO:0043967 |
10 |
0.156
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.155
|
Mouse |
|
|
neural tube development
|
GO:0021915 |
160 |
0.153
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.151
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.151
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.143
|
Mouse |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.140
|
Mouse |
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.130
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.127
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.123
|
|
|
|
maintenance of chromatin silencing
|
GO:0006344 |
2 |
0.115
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.115
|
Mouse |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.113
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.112
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.112
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.108
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.107
|
|
|
|
histone acetylation
|
GO:0016573 |
41 |
0.106
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.103
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.101
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.098
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.096
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.094
|
|
|
|
chromatin disassembly
|
GO:0031498 |
1 |
0.091
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.090
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.089
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.087
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.087
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.086
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.085
|
Mouse |
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
88 |
0.085
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.080
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.080
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.077
|
|
|
|
protein dna complex disassembly
|
GO:0032986 |
1 |
0.077
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.075
|
|
|
|
internal protein amino acid acetylation
|
GO:0006475 |
42 |
0.066
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.065
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.065
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.064
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.063
|
Mouse |
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.063
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.063
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.063
|
Mouse |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.062
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.062
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.061
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
31 |
0.060
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.060
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.060
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.059
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.059
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.058
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.056
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
98 |
0.056
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.055
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.055
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.055
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.055
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.054
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.054
|
|
|
|
protein polyubiquitination
|
GO:0000209 |
33 |
0.054
|
Mouse |
|
|
male gamete generation
|
GO:0048232 |
285 |
0.053
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.053
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.053
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.053
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.053
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.052
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.051
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.051
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.050
|
|
|
|
regulation of schwann cell proliferation
|
GO:0010624 |
2 |
0.050
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.049
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.049
|
Mouse |
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.049
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.048
|
Mouse |
|
|
rhythmic process
|
GO:0048511 |
174 |
0.048
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.048
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.048
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.047
|
|
|
|
internal peptidyl lysine acetylation
|
GO:0018393 |
42 |
0.047
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.047
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.047
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.046
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.046
|
|
|
|
regulation of histone methylation
|
GO:0031060 |
30 |
0.046
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.046
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.045
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.044
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.044
|
|
|
|
positive regulation of cell proliferation involved in heart valve morphogenesis
|
GO:0003251 |
1 |
0.043
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.043
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.043
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.043
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.042
|
Mouse |
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.042
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.042
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.041
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.041
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.041
|
Mouse |
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.040
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
34 |
0.040
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.040
|
Mouse |
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.040
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.039
|
Mouse |
|
|
transcription elongation from rna polymerase ii promoter
|
GO:0006368 |
9 |
0.038
|
|
|
|
schwann cell proliferation
|
GO:0014010 |
2 |
0.038
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.038
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.038
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.038
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.038
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.037
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.036
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.036
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.036
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.035
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.034
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.034
|
|
|
|
histone h3 k4 trimethylation
|
GO:0080182 |
5 |
0.034
|
|
|
|
negative regulation of peptidyl threonine phosphorylation
|
GO:0010801 |
6 |
0.034
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.034
|
Mouse |
|
|
negative regulation of cell growth
|
GO:0030308 |
44 |
0.034
|
Mouse |
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.033
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.033
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.033
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.032
|
|
|
|
blastocyst formation
|
GO:0001825 |
33 |
0.032
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.032
|
|
|
|
regulation of transcription involved in g1 s transition of mitotic cell cycle
|
GO:0000083 |
3 |
0.032
|
|
|
|
regulation of response to drug
|
GO:2001023 |
2 |
0.032
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.032
|
|
|
|
positive regulation of smad protein import into nucleus
|
GO:0060391 |
2 |
0.032
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.032
|
|
|
|
regulation of clathrin mediated endocytosis
|
GO:2000369 |
4 |
0.032
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.031
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.031
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.031
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.031
|
Mouse |
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.030
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.030
|
Mouse |
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.030
|
Mouse |
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.030
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.030
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.029
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.029
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.029
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.029
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.029
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.028
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.028
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.028
|
|
|
|
peptidyl lysine acetylation
|
GO:0018394 |
45 |
0.028
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.028
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.028
|
|
|
|
protein homooligomerization
|
GO:0051260 |
43 |
0.028
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.028
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.028
|
|
|
|
protein localization to cell junction
|
GO:1902414 |
3 |
0.028
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.027
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.027
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.027
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.027
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.026
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.026
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.026
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.025
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.025
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.025
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.025
|
|
|
|
cell proliferation involved in heart valve morphogenesis
|
GO:0003249 |
1 |
0.025
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.025
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.025
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.025
|
Mouse |
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.025
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.025
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.025
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.025
|
Mouse |
|
|
liver development
|
GO:0001889 |
66 |
0.025
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.025
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.025
|
Mouse |
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
53 |
0.025
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.024
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.024
|
|
|
|
negative regulation of bmp signaling pathway
|
GO:0030514 |
35 |
0.024
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.024
|
|
|
|
negative regulation of glial cell proliferation
|
GO:0060253 |
4 |
0.024
|
|
|
|
positive regulation of chromatin modification
|
GO:1903310 |
28 |
0.024
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
19 |
0.024
|
Mouse |
|
|
nodal signaling pathway involved in determination of lateral mesoderm left right asymmetry
|
GO:1900164 |
2 |
0.024
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.024
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.023
|
|
|
|
regulation of androgen receptor signaling pathway
|
GO:0060765 |
3 |
0.023
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
68 |
0.023
|
|
|
|
protein homotrimerization
|
GO:0070207 |
4 |
0.023
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.023
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.023
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.023
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.023
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.023
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.023
|
Mouse |
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.022
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.022
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.022
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.022
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.022
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.021
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.021
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.021
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.021
|
|
|
|
localization within membrane
|
GO:0051668 |
4 |
0.021
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.021
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.021
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.021
|
|
|
|
viral gene expression
|
GO:0019080 |
3 |
0.021
|
|
|
|
nodal signaling pathway involved in determination of left right asymmetry
|
GO:0038107 |
2 |
0.021
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.021
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.021
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.021
|
|
|
|
regulation of transcription from rna polymerase ii promoter involved in determination of left right symmetry
|
GO:1900094 |
2 |
0.021
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.020
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.020
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.020
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.020
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.020
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.020
|
|
|
|
regulation of transcription during meiosis
|
GO:0051037 |
1 |
0.020
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.020
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.020
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.020
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.020
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
48 |
0.020
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.020
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.019
|
Mouse |
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.019
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.019
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.019
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.019
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.019
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.019
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.019
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.019
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.019
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.019
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.019
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.019
|
|
|
|
sensory organ boundary specification
|
GO:0008052 |
1 |
0.019
|
|
|
|
histone h3 k4 methylation
|
GO:0051568 |
23 |
0.019
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.019
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.019
|
|
|
|
establishment of planar polarity of embryonic epithelium
|
GO:0042249 |
16 |
0.019
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.019
|
|
|
|
mesonephric tubule development
|
GO:0072164 |
94 |
0.019
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.018
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.018
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.018
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.018
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.018
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.018
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.018
|
Mouse |
|
|
nephrogenic mesenchyme morphogenesis
|
GO:0072134 |
2 |
0.018
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.018
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.018
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.017
|
|
|
|
endocardial cell differentiation
|
GO:0060956 |
4 |
0.017
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.017
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.017
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.017
|
|
|
|
positive regulation of chromatin binding
|
GO:0035563 |
3 |
0.017
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.017
|
|
|
|
dna methylation
|
GO:0006306 |
43 |
0.017
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.017
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.017
|
Mouse |
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.017
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.017
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.017
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.017
|
|
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.017
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.017
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.017
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.017
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.017
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.017
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.017
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.017
|
Mouse |
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.017
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.017
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.017
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.016
|
Mouse |
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.016
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.016
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.016
|
|
|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.016
|
|
|
|
regulation of cardiac cell fate specification
|
GO:2000043 |
1 |
0.016
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.016
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.016
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.016
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.016
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.016
|
|
|
|
negative regulation of osteoblast proliferation
|
GO:0033689 |
4 |
0.016
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.016
|
|
|
|
definitive erythrocyte differentiation
|
GO:0060318 |
7 |
0.015
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.015
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.015
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.015
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.015
|
Mouse |
|
|
antimicrobial peptide production
|
GO:0002775 |
2 |
0.015
|
|
|
|
actin filament based movement
|
GO:0030048 |
23 |
0.015
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.015
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.015
|
|
|
|
cell cycle arrest
|
GO:0007050 |
37 |
0.015
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.015
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.015
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.015
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.015
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.015
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.015
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.015
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.014
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.014
|
|
|
|
ureteric bud development
|
GO:0001657 |
94 |
0.014
|
|
|
|
white fat cell differentiation
|
GO:0050872 |
15 |
0.014
|
|
|
|
regulation of transcription elongation from rna polymerase ii promoter
|
GO:0034243 |
9 |
0.014
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.014
|
|
|
|
macromolecular complex disassembly
|
GO:0032984 |
43 |
0.014
|
|
|
|
regulation of endoplasmic reticulum stress induced intrinsic apoptotic signaling pathway
|
GO:1902235 |
11 |
0.014
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.014
|
|
|
|
photoreceptor cell morphogenesis
|
GO:0008594 |
3 |
0.014
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.014
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.014
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.014
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.014
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.014
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.014
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.014
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.014
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.014
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.014
|
|
|
|
activation of mapkkk activity
|
GO:0000185 |
1 |
0.014
|
|
|
|
toxin transport
|
GO:1901998 |
38 |
0.014
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.014
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.014
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.014
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.014
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.014
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.014
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.014
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.013
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.013
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.013
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.013
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.013
|
|
|
|
regulation of antimicrobial peptide production
|
GO:0002784 |
1 |
0.013
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.013
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.013
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.013
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.013
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.013
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.013
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.013
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.013
|
|
|
|
histone h3 acetylation
|
GO:0043966 |
14 |
0.013
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.013
|
|
|
|
histone h3 k14 acetylation
|
GO:0044154 |
3 |
0.013
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.013
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.013
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.013
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.013
|
|
|
|
peptidyl lysine trimethylation
|
GO:0018023 |
12 |
0.013
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.013
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.013
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.013
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.013
|
|
|
|
positive regulation of dendrite development
|
GO:1900006 |
21 |
0.013
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.013
|
|
|
|
face development
|
GO:0060324 |
38 |
0.013
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
pigment accumulation
|
GO:0043476 |
1 |
0.012
|
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.012
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.012
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.012
|
|
|
|
histone h3 k9 dimethylation
|
GO:0036123 |
4 |
0.012
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.012
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.012
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.012
|
|
|
|
mitochondrion distribution
|
GO:0048311 |
4 |
0.012
|
|
|
|
histone deubiquitination
|
GO:0016578 |
2 |
0.012
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.012
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.012
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.012
|
|
|
|
stem cell fate specification
|
GO:0048866 |
3 |
0.012
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.012
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.012
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.012
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.012
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.012
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.012
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.012
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.012
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.012
|
|
|
|
oligodendrocyte differentiation
|
GO:0048709 |
53 |
0.012
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.012
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.012
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.012
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.012
|
|
|
|
dna endoreduplication
|
GO:0042023 |
4 |
0.012
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.012
|
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.012
|
|
|
|
kidney mesenchyme morphogenesis
|
GO:0072131 |
4 |
0.012
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.011
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.011
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.011
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.011
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.011
|
|
|
|
learning
|
GO:0007612 |
98 |
0.011
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.011
|
|
|
|
regulation of activin receptor signaling pathway
|
GO:0032925 |
10 |
0.011
|
|
|
|
compartment pattern specification
|
GO:0007386 |
4 |
0.011
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
52 |
0.011
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.011
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.011
|
Mouse |
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.011
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.011
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.011
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.011
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.011
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.011
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.011
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.011
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.011
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.011
|
|
|
|
positive regulation of megakaryocyte differentiation
|
GO:0045654 |
4 |
0.011
|
|
|
|
sebaceous gland development
|
GO:0048733 |
7 |
0.011
|
|
|
|
positive regulation of mesoderm development
|
GO:2000382 |
2 |
0.011
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.011
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.011
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.011
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.011
|
|
|
|
dna alkylation
|
GO:0006305 |
43 |
0.011
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.011
|
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.011
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.011
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.011
|
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.011
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.011
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.010
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.010
|
|
|
|
male meiosis
|
GO:0007140 |
37 |
0.010
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.010
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.010
|
|